AMA Offers Resources to Help Docs' Collections

Share this content:
AMA Offers Resources to Help Docs' Collections
AMA Offers Resources to Help Docs' Collections

(HealthDay News) — The American Medical Association (AMA) has released resources to help doctors confront policy jumpers who may pose a financial risk to physicians during the Affordable Care Act's 90-day premium grace period, according to an article published March 25 in Medical Economics.

The article describes this controversial grace period rule, which deals with patients who are delinquent in paying their monthly premiums, but who are still eligible to keep their coverage for 90 days.

Insurers will be responsible for reimbursing claims for services provided to the patient during the first 30 days, but for the remaining 60 days, insurers may deny claims, leaving physicians carrying the bill.

RELATED: Practice Management Resource Center

While the AMA continues to fight this policy, they have released several resources to aid physicians in collecting payment.

According to the article, these resources include a grace period collections policy checklist that encourages providers to verify insurance eligibility; a model financial agreement language for patients receiving Advance Premium Tax Credits; and a sample letter providing notice of the grace period to patients. Resources also include tips on how to establish payment plans and communicate billing policies to patients.

"Managing risk is typically a role for insurers, but the grace period rule transfers two-thirds of that risk from the insurers to physicians and health care providers," said Ardis Dee Hoven, MD, president of the AMA, according to the Medical Economics article. "The AMA is helping physicians take proactive steps to minimize these risks."

More Information

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs